Katell Le Du (Katell Le Dû)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Neuropathic Pain

Top Venues

Journal of medical Internet research

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hughes Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study. Journal of medical Internet research 25 (2023)
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hughes Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study. Journal of medical Internet research 25 (2023)
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hughes Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study. Journal of medical Internet research 25 (2023)
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hughes Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study. Journal of medical Internet research 25 (2023)
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hughes Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study. Journal of medical Internet research 25 (2023)
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hughes Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study. Journal of medical Internet research 25 (2023)
Jonas Dubu, Sébastien Boyas, Virginie Roland, Sébastien Landry, Anne-Lise Septans, Magali Balavoine, Hughes Bourgeois, Yoann Pointreau, Fabrice Denis, Christophe Letellier, Katell Le Du
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial. JMIR research protocols 11 (11) (2022)
Katell Le Du, Nicolas Alarion, Hassan Rabi, Olivier Casasnovas, Philippine Robert, Amandine Durand, Bénédicte Burlet, Claire Tabouret-Viaud, Selim Ramla, Laurent Martin, Cédric Rossi
Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature. CNS oncology 11 (3) (2022)
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Gandhi Laurent Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood advances 5 (19) (2021)